Skip to content

Longitudinal Survey Analysis in Lymphoma Survivors

Coping With Lymphoma to Enhance Adjustment and Reduce Stress in Lymphoma Survivors

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01469754
Acronym
CLEAR Stress
Enrollment
97
Registered
2011-11-10
Start date
2011-09-30
Completion date
2013-09-30
Last updated
2014-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coping, Lymphoma, Posttraumatic Growth, Posttraumatic Stress Disorder, Resilience

Keywords

lymphoma, survivors, posttraumatic growth, posttraumatic stress, longitudinal

Brief summary

Posttraumatic Stress Disorder (PTSD) is a well-documented phenomenon that occurs in cancer survivors. PTSD is known to cause problems with anxiety, depression, and quality of life. Furthermore, there is little treatment available for cancer survivors who suffer from PTSD. Posttraumatic Growth, however, is a lesser known phenomenon that also occurs in cancer survivors. It is a positive psychological phenomenon that occurs in some people who have suffered a traumatic event--the people who are able to note a greater appreciation for life, a stronger relationship with their family/friends, or a new found level of spirituality are examples of instances of posttraumatic growth. Coping with Lymphoma to Enhance Adjustment and Reduce Stress in Survivors (CLEAR Stress) is a study designed to compare the development of PTSD versus the development of Posttraumatic Growth in lymphoma patients at any stage of the cancer experience, regardless of treatment. The hypothesis is that posttraumatic growth, if it is significant, can reduce the impact of PTSD symptoms in the survivor.

Interventions

None listed

Sponsors

Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Diagnosis of Lymphoma (includes Waldenstrom's Macroglobulinemia) * Can read/write/understand English without a translator

Exclusion criteria

* Currently Hospitalized * Active Psychosis

Design outcomes

Primary

MeasureTime frame
Posttraumatic GrowthMeasured at enrollment

Secondary

MeasureTime frame
Posttraumatic Stress Disorder (PTSD)Measured at Enrollment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026